Investigation Research
Reliability and validity of Chinese version of Xerostomia Questionnaire in nasopharyngeal carcinoma patients undergoing radiotherapy
Lin Wang, Manyi Zhu, Yuqing Huang, Jiawen Huang, Boyu Chen, Muping Di, Jingjing Miao, Chong Zhao
Published 2019-08-15
Cite as Chin J Radiat Oncol, 2019, 28(8): 566-570. DOI: 10.3760/cma.j.issn.1004-4221.2019.08.002
Abstract
ObjectiveTo evaluate the validity and reliability of the Chinese version of Xerostomia Questionnaire (XQ-C) in nasopharyngeal carcinoma patients treated with radiotherapy.
MethodsXQ-C was translated according to the International Quality of Life Assessment project approach. Patients with nasopharyngeal carcinoma in different radiotherapy stages were enrolled in this study and assessed by using the XQ-C. The validity and reliability of the questionnaire results were evaluated. The content validity was assessed by experts grading method. The construct validity was assessed by exploratory factor analysis. The discriminant validity was determined by non-parametric method. The reliability was evaluated by Cronbach′s α and split-half reliability to assess the internal consistency.
ResultsA total of 212 questionnaires were completely filled out. Content validity showed that the item content validity index (I-CVI) ≥0.80, Scale-CVI/Ave=0.97, and P value of Kendall′s W test was 0.701. Exploratory factor analysis revealed that XQ-C was a unidimensional scale. The scale scores of patients at different stages of radiotherapy significantly differed, suggesting that the discriminant validity was good. Cronbach′s α of the scale was 0.951 and Guttman′s semi-reliability coefficient was 0.940.
ConclusionThe XQ-C is valid and reliable, which can be widely applied in the clinical diagnosis, treatment and research of xerostomia in Chinese nasopharyngeal carcinoma patients after radiotherapy.
Key words:
Nasopharyngeal carcinoma; Xerostomia Questionnaire; Validity; Reliability
Contributor Information
Lin Wang
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China
Manyi Zhu
Yuqing Huang
Jiawen Huang
Boyu Chen
Muping Di
Jingjing Miao
Chong Zhao